 2 case control studies including
a total of 476, 266 patients undergoing a variety of superﬁcial endovenous interventions with exclusion of open
venous surgery.32 Notably, most studies excluded patients with a history of DVT. Although signiﬁcant heterogeneity precluded analysis of all study arms, among
prospective studies additional pharmacological prophylaxis reduced the incidence of DVT to 0.73% (95%